06/17/2025
7:17 PM | Acrivon Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
4:48 PM | Acrivon Therapeutics (Issuer)
Magovcevic-Liebisch Ivana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
4:49 PM | Acrivon Therapeutics (Issuer)
Palani Santhosh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
4:54 PM | Acrivon Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
4:57 PM | Acrivon Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
5:04 PM | Acrivon Therapeutics (Issuer)
DiRocco Derek (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
4:21 PM | Acrivon Therapeutics (Issuer)
BAUM CHARLES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:05 PM | Acrivon Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/23/2025
3:58 PM | Acrivon Therapeutics (Issuer)
Blume-Jensen Peter (Reporting)
Masson Kristina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
4:24 PM | Acrivon Therapeutics (Subject)
CITADEL ADVISORS LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025
3:47 PM | Acrivon Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Get the Latest News and Ratings for ACRV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/14/2025
3:16 PM | Acrivon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2025
7:21 PM | Acrivon Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/01/2025
6:07 PM | Acrivon Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2025
6:26 PM | Acrivon Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2025
7:34 AM | Acrivon Therapeutics (Filer)
| Form ARS | |
04/25/2025
7:30 AM | Acrivon Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
7:32 AM | Acrivon Therapeutics (Filer)
| Form DEFA14A | |
04/21/2025
3:22 PM | Acrivon Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2025
3:32 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:28 PM | Acrivon Therapeutics (Issuer)
Levy Adam D. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2025
3:30 PM | Acrivon Therapeutics (Issuer)
Levy Adam D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
8:08 AM | Acrivon Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2025
3:48 PM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
4:15 PM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2025
3:44 PM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
4:36 PM | Acrivon Therapeutics (Issuer)
Peterson Katharine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:28 PM | Acrivon Therapeutics (Issuer)
Holm-Jorgensen Rasmus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:31 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:52 PM | Acrivon Therapeutics (Issuer)
Blume-Jensen Peter (Reporting)
Masson Kristina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:53 PM | Acrivon Therapeutics (Issuer)
Devroe Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:54 PM | Acrivon Therapeutics (Issuer)
Gamelin Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:55 PM | Acrivon Therapeutics (Issuer)
Holm-Jorgensen Rasmus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:59 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:04 PM | Acrivon Therapeutics (Issuer)
Blume-Jensen Peter (Reporting)
Masson Kristina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:06 PM | Acrivon Therapeutics (Issuer)
Devroe Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:08 PM | Acrivon Therapeutics (Issuer)
Gamelin Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:10 PM | Acrivon Therapeutics (Issuer)
Holm-Jorgensen Rasmus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:11 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
6:06 AM | Acrivon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
6:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Small Washington, DC Group Could Crash US Stocks (Ad) New Amazon Crisis Could Tank U.S. Stock Market
A new panic is halting AI projects at Amazon and could split the entire U.S. market in two on or before Sept 30, causing a crisis "many times worse than 2008." Click here for full details while you still have time to move your money. |
10/21/2024
3:22 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
7:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
5:49 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
5:43 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
3:52 PM | Acrivon Therapeutics (Issuer)
Miller Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
3:53 PM | Acrivon Therapeutics (Issuer)
Peterson Katharine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
7:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:36 AM | Acrivon Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
